DiaMedica Therapeutics Inc.
6 private offerings reported to the SEC on Form D since 2016, $110.4M sold in all. Biotech, MN.
- Form D offerings: 6
- Reported sold: $110.4M
- Newest: Jul 25, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Jul 25, 2025 | $30.1M | $30.1M | DiaMedica Therapeutics Inc.Biotech · MN | Not amended | 0001437749-25-023439 |
| Jul 2, 2024 | $11.8M | $11.8M | DiaMedica Therapeutics Inc.Biotech · MN | Not amended | 0001235802-24-000055 |
| Jun 27, 2023 | $37.5M | $37.5M | DiaMedica Therapeutics Inc.Biotech · MN | Not amended | 0001235802-23-000074 |
| Apr 18, 2023 | $750K | $750K | DiaMedica Therapeutics Inc.Biotech · MN | Not amended | 0001235802-23-000041 |
| Oct 6, 2021 | $30.0M | $30.0M | DiaMedica Therapeutics Inc.Biotech · MN | Not amended | 0001235802-21-000122 |
| Apr 17, 2018 | $201K | $344K | DiaMedica Therapeutics Inc.Biotech · MN | Not amended | 0001140361-18-018770 |
SEC Profile
From the company's EDGAR record- Ticker
- DMAC
- Business address
- Minneapolis, Mn
- Incorporated in
- Canada (Federal Level)
- SEC industry
- Pharmaceutical Preparations
- Former names
- DiaMedica Inc.
- All SEC filings
- CIK 1401040 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR